BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 3.69M |
Day Range | - - - |
52 Wk Range | 4.03 - 7.95 |
Market Cap | $1.35B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 14.5% |
Days to Cover | 9.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Arcutis Biotherapeutics (NASDAQ:ARQT), Immatics (NASDAQ:IMTX), Prothena Corp (NASDAQ:PRTA) and Day One Biopharmaceutical (NASDAQ:DAWN).
There is no analysis for BioCryst Pharma.
BioCryst Pharma has a consensus price target of $13.83.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $6.55 last updated July 2, 2024 at 4:00 PM EDT.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.